TechMediaBreaks – Fifty 1 Labs, Inc. (OTC: FITY) Reports Strong Shareholder Engagement in Virtual Teleconference Highlighting AI-Driven Growth Strategy
Fifty 1 Labs (OTC: FITY), a pioneer in AI-powered health and wellness solutions, successfully hosted its July 28 virtual shareholder teleconference via X (formerly Twitter), outlining its transformative strategy through subsidiary Fifty 1 AI Labs. CEO Paul Arora detailed the company’s AI-driven drug repurposing platform targeting the $320.6 billion functional medicine market and $5.68 trillion biotech sector, supported by a $350,000 personal investment and salary deferrals from management until reaching a $50 million valuation. Key initiatives include a $1 million R&D investment, a targeted $5–10 million biotech acquisition by 2027, and planned uplisting to OTCQB in 2026 and NASDAQ thereafter.…